Rhea-AI Summary
Avalyn Pharma Inc. filed an initial insider ownership report for its General Counsel, Adam H. Golden. The Form 3 lists him as an officer but does not report any share transactions or derivative positions, indicating this filing is purely administrative disclosure of insider status rather than trading activity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Avalyn Pharma (AVLN) SEC filings are available on StockTitan?
StockTitan tracks 32 SEC filings for Avalyn Pharma (AVLN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Avalyn Pharma (AVLN)?
The most recent SEC filing for Avalyn Pharma (AVLN) was filed on April 29, 2026.